KFDA Bans Antipsychotic Drugs Containing Thioridazine Hydrochloride

Published: 2005-04-06 06:59:00

Updated: 2005-04-06 06:59:00

The Korea Food and Drug Administration (KFDA) recently announced of a decision to ban the antipsychotic drugs containing thioridazine hydrochloride in the domestic market effective July of this year.

The decision is made based on the announcement by Novartis earlier this year to voluntarily wi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK